Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program

Henry Krum1* Sean P. Curtis2 Amarjot Kaur2 Hongwei Wang2 Steven S. Smugar2 Matthew R. Weir3 Loren Laine4 D. Craig Brater5 and Christopher P. Cannon6

首页> 外文期刊>European Journal of Heart Failure >Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program

【24h】

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program

机译：接受依托昔布或双氯芬酸患者充血性心力衰竭相关的基线因素：MEDAL计划的多变量分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims Non-steroidal anti-inflammatory drugs have been associated with increased risk of congestive heart failure (CHF). We aimed to assess the impact of treatment with etoricoxib or diclofenac on risk of CHF relative to baseline risk factors.

机译：目的非甾体类抗炎药与充血性心力衰竭（CHF）的风险增加有关。我们旨在评估依托考昔或双氯芬酸治疗相对于基线风险因素对CHF风险的影响。

著录项

来源
《European Journal of Heart Failure》 |2009年第6期|p.542-550|共9页
作者
Henry Krum1* Sean P. Curtis2 Amarjot Kaur2 Hongwei Wang2 Steven S. Smugar2 Matthew R. Weir3 Loren Laine4 D. Craig Brater5 and Christopher P. Cannon6;
展开▼
作者单位

1Department of Epidemiology and Preventive Medicine, NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Alfred Hospital, Melbourne Vic 3004, Australia 2Merck Research Laboratories, Rahway, NJ, USA 3Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD, USA 4Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA 5Indiana University School of Medicine, Indianapolis, IN, USA 6TIMI Study Group, Brigham and Women’s Hospital, Boston, MA, USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. [J] . Krum H, Curtis SP, Kaur European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2009,第6期

机译：接受依托昔布或双氯芬酸患者充血性心力衰竭相关的基线因素：MEDAL计划的多变量分析。
2. The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists. [J] . Cole J, Busti A, Kazi S Rheumatology international. . 2007,第4期

机译：接受肿瘤坏死因子α拮抗剂的退伍军人事务患者新发充血性心力衰竭和心力衰竭加重的发生率。
3. The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran’s Affairs patients receiving tumor necrosis factor alpha antagonists [J] . Jennifer Cole, Anthony Busti, Salahuddin Kazi Rheumatology International . 2007,第4期

机译：接受肿瘤坏死因子α拮抗剂的退伍军人患者新发充血性心力衰竭和心力衰竭加重的发生率
4. Analysis Of Heart Rate Variation By Fourier Analysis In A Group Of Patients Diagnosed With Congestive Heart Failure [C] . Naiereik, S.M., Bull, Engineering in Medicine and Biology Society, 1991. Vol.13: 1991., Proceedings of the Annual International Conference of the IEEE . 1991

机译：通过傅里叶分析对一组诊断为充血性心力衰竭的患者的心率变化进行分析
5. Factors associated with medication adherence of patients with congestive heart failure [D] . Fung, Sharon Chyihuey 2009

机译：充血性心力衰竭患者药物依从性的相关因素
6. Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials [O] . Wei-Xiang Qi, Zan Shen, Li-Na Tang, 2014

机译：血管内皮生长因子酪氨酸激酶抑制剂治疗的癌症患者的充血性心力衰竭风险：36项临床试验的系统评价和荟萃分析
7. Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis” [O] . Robert S. Zimmerman, Kevin Matthew Pantalone 2009

机译：致编辑的信Re：MD博士博士致编辑的信，关于“发育冠状动脉疾病或充血性心力衰竭的风险，以及在2型糖尿病患者接受Rosiglitazone，Pioglitazone，二甲双胍，或磺脲类：回顾性分析“

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program

摘要

著录项

相似文献

相关主题

期刊订阅